Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 32% ± 17% | |
adipocyte | 6 studies | 30% ± 8% | |
cardiac muscle cell | 5 studies | 27% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 5% | |
hepatocyte | 3 studies | 33% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 1299.77 | 2561 / 2642 | 98% | 7.05 | 693 / 705 |
prostate | 100% | 2906.62 | 244 / 245 | 95% | 5.24 | 479 / 502 |
liver | 100% | 4443.90 | 226 / 226 | 94% | 7.84 | 382 / 406 |
thymus | 99% | 1988.39 | 648 / 653 | 92% | 2.59 | 554 / 605 |
kidney | 99% | 1595.78 | 88 / 89 | 85% | 3.07 | 767 / 901 |
adrenal gland | 95% | 1228.58 | 244 / 258 | 65% | 1.32 | 150 / 230 |
breast | 98% | 1840.96 | 451 / 459 | 60% | 1.46 | 667 / 1118 |
pancreas | 99% | 1663.94 | 324 / 328 | 59% | 0.97 | 105 / 178 |
ovary | 97% | 3711.16 | 175 / 180 | 58% | 1.16 | 248 / 430 |
uterus | 96% | 1823.05 | 164 / 170 | 47% | 1.16 | 218 / 459 |
skin | 70% | 555.52 | 1264 / 1809 | 62% | 1.99 | 293 / 472 |
lung | 90% | 1282.79 | 518 / 578 | 37% | 0.87 | 430 / 1155 |
bladder | 90% | 2435.57 | 19 / 21 | 32% | 0.80 | 161 / 504 |
esophagus | 91% | 2182.92 | 1310 / 1445 | 25% | 0.60 | 45 / 183 |
stomach | 100% | 2935.26 | 358 / 359 | 7% | 0.14 | 20 / 286 |
intestine | 98% | 1750.78 | 943 / 966 | 4% | 0.07 | 19 / 527 |
muscle | 100% | 3175.73 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 1437.39 | 238 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2418.07 | 1316 / 1335 | 0% | 0 | 0 / 0 |
adipose | 97% | 1803.17 | 1164 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 2142.07 | 823 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 3.09 | 68 / 80 |
lymph node | 0% | 0 | 0 / 0 | 45% | 0.81 | 13 / 29 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.39 | 12 / 45 |
peripheral blood | 17% | 100.16 | 158 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006103 | Biological process | 2-oxoglutarate metabolic process |
GO_0006539 | Biological process | glutamate catabolic process via 2-oxoglutarate |
GO_0006629 | Biological process | lipid metabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0047988 | Molecular function | hydroxyacid-oxoacid transhydrogenase activity |
GO_0004022 | Molecular function | alcohol dehydrogenase (NAD+) activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ADHFE1 |
Protein name | Hydroxyacid-oxoacid transhydrogenase, mitochondrial (Alcohol dehydrogenase iron-containing protein 1) Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) (Fe-containing alcohol dehydrogenase) Alcohol dehydrogenase iron containing 1 |
Synonyms | HMFT2263 |
Description | FUNCTION: Catalyzes the cofactor-independent reversible oxidation of gamma-hydroxybutyrate (GHB) to succinic semialdehyde (SSA) coupled to reduction of 2-ketoglutarate (2-KG) to D-2-hydroxyglutarate (D-2-HG). D,L-3-hydroxyisobutyrate and L-3-hydroxybutyrate (L-3-OHB) are also substrates for HOT with 10-fold lower activities. . |
Accessions | ENST00000424777.6 [Q8IWW8-3] Q8IWW8 ENST00000443372.5 ENST00000426810.5 ENST00000415254.5 [Q8IWW8-2] ENST00000419955.5 F2Z3E5 ENST00000396621.7 F2Z2N0 B4DV11 ENST00000276576.11 ENST00000396623.8 [Q8IWW8-1] B4DFI7 ENST00000431959.5 ENST00000422166.5 F2Z3D8 ENST00000449512.5 |